CyberSweep, based in Denver, CO, provides cybersecurity due diligence and dollar-based risk quantification for mergers, acquisitions and private equity deals. In M&A cyber due diligence, CyberSweep focuses on the connection between technical exposure and financial intelligence—a distinction that puts the business consequences of cyber risk alongside the technology questions.
CyberSweep’s Denver Business Centers on Deal Economics
Established around 2021, CyberSweep describes its purpose as turning cyber risk into financial intelligence. Its stated business is cybersecurity due diligence and dollar-based risk quantification for M&A and PE deals, rather than an unspecified range of technology services. That description identifies both a transaction setting and a financial frame: the subject is cyber exposure, but the intended language is dollars. The distinction matters when describing the company accurately. CyberSweep’s stated focus does not, by itself, establish a particular assessment methodology, delivery timetable or transaction outcome. It does establish that acquisition-related cybersecurity and the financial expression of risk sit together in its offering.
The company’s listed offerings include DeepSweep™+ the RDA™, Portfolio Shield™ and Exit Readiness. Its website also identifies Healthcare Services and Life Sciences / Pharma / CROs, alongside topics concerning ransomware planted before a deal closes, the impact of cyber breaches on dealflow, and regulatory exposure that moves valuations. Those names and topics describe the scope presented by the business; they should not be treated as evidence of particular client engagements or completed deals. Taken together, the supplied business information places CyberSweep within a defined category: a Denver company addressing cybersecurity in the context of investment transactions and financial exposure. Its service names provide a starting point for understanding that positioning, without supplying enough detail to compare individual packages or characterize their underlying procedures.
Denver Dealmakers Face a Cyber Diligence Measurement Gap
The broader private equity market supplies a useful benchmark, but not a Denver market estimate. S-RM’s 2025 report, From Awareness to Action—Cyber Resilience in Private Equity, found that 70% of surveyed private equity respondents conducted cyber due diligence on every acquisition target. The denominator matters: this is a finding about surveyed respondents, not a count of Denver transactions, and it does not establish how much firms spent or how extensive their assessments were. No verified Denver-specific cyber due diligence market size or growth rate for 2026 is available in the supplied market context. For a regional business audience, the defensible conclusion is therefore narrower than a local growth claim: cyber diligence was a recurring acquisition practice among a substantial share of that survey’s respondents. Applying the percentage directly to Denver would substitute an assumption for local evidence. It would also confuse adoption of a process with demand for any particular provider, service package or pricing model.
For Denver, the analytical question is how a transaction-focused specialty fits into the local business economy—not whether a national survey proves a local boom. The U.S. Census Bureau’s business and economy resources provide a public starting point for examining business conditions, while Federal Reserve Economic Data provides broader economic context. Neither resource is presented here as a measurement of Denver cyber diligence spending, and neither validates a company-specific demand forecast. A credible local estimate would require evidence connecting acquisition activity, assessment purchasing and the geographic definition of the market. That distinction is particularly important for a specialized service: the number of businesses in a region is not equivalent to the number seeking acquisition-related cyber work. The practical issue for dealmakers is also more specific than whether an assessment occurs. A transaction needs a way to distinguish a technical finding from its possible financial consequence, while preserving uncertainty rather than disguising it with a precise-looking number. A dollar estimate is useful only to the extent that its assumptions and boundaries are understood. Those are general considerations for evaluating this service category, not findings about CyberSweep’s methods or performance. They explain why a Denver business offering dollar-based cyber risk quantification belongs in a discussion of transaction economics, even when the available evidence cannot support claims about the size or growth of its local market.
DeepSweep, Portfolio Shield and Exit Readiness Define the Listed Offering
CyberSweep offers cybersecurity due diligence and dollar-based risk quantification for M&A and PE deals. Its listed offerings are DeepSweep™+ the RDA™, Portfolio Shield™ and Exit Readiness, and its website names Healthcare Services and Life Sciences / Pharma / CROs. The site’s stated topics include ransomware planted before a deal closes, cyber breaches and their impact on dealflow, and regulatory exposure that moves valuations. The company describes this work with the phrase “Turn cyber risk into financial intelligence.”
The regional business story is the meeting point between a Denver provider’s stated specialty and a wider acquisition practice documented by the private equity survey. Keeping those two kinds of evidence separate makes the account more useful: the company information establishes what CyberSweep offers, while the survey supplies a broader benchmark without proving local growth, customer outcomes or market share. For readers evaluating the category, that boundary leaves room for substantive questions about scope and financial assumptions without pretending the available information answers them. CyberSweep’s published business and offering information is available at cybersweep.io.
Further reading from The Capital Front: CyberSweep Brings Dollar-Based Cyber Risk Quantification to Denver’s Deal Economy and Millennium Medical and the Washington Region’s Cosmetic Surgery Market.